Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study

Mar-23

AUTHORS : Abdel Aziz Shaheen, Division of Gastroenterology and Hepatology, Department of Medicine and Community Health Sciences, O’Brian Institute for Public Health Cumming, School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 6D25 Calgary, AB, Canada T2N 4Z6. E-mail: az.shaheen@ucalgary.ca

JOURNAL : Hepatology Communications

REFERENCE: 2023;7:e0062.

DOI : 10.1097/HC9.0000000000000062

Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study

More publications

Machine learning prediction algorithms for 2- , 5- and 10-year risk of Alzheimer’s, Parkinson’s and dementia at age 65: a study using medical records from France and the UK General Practitioners

Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study

Maternal perinatal anxiety and infant primary care use in 1998–2016: a UK cohort study